Jean-François Morin

Jean-François Morin is the current director at TISSIUM. Jean-François has also been a board member at ONA Therapeutics, TISSIUM, Hello Tomorrow Nonprofit, and Therachon. In addition, they have served as president of the audit committee and investment director of life sciences for venture capital at Bpifrance.

Morin has extensive experience in deep technology and startups. Jean-François is passionate about connecting people and initiatives to create a better future. Through their work with Hello Tomorrow, they have been able to connect thousands of the world's brightest talents and help bring breakthrough technology to market.

Jean-François Morin has a Master in Finance from EDHEC Business School, a Certificat Administrateur de Sociétés from Institut Français des Administrateurs, a Cycle Capital Investissement from AFIC - Association Française des Investisseurs pour la Croissance, and a BA in European Economics and Management from the University Of Abertay. Jean-François also has certification from the Autorité des marchés financiers (AMF) – France in Certification Professionnelle des acteurs de marchés.